- Home
- USPH vs NAGE Comparison
USPH vs NAGE Comparison
Compare USPH & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- NAGE
- Stock Information
- Founded
- USPH 1990
- NAGE 1999
- Country
- USPH United States
- NAGE United States
- Employees
- USPH N/A
- NAGE N/A
- Industry
- USPH Medical/Nursing Services
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- USPH Health Care
- NAGE Health Care
- Exchange
- USPH Nasdaq
- NAGE Nasdaq
- Market Cap
- USPH 1.1B
- NAGE 861.0M
- IPO Year
- USPH 1992
- NAGE N/A
- Fundamental
- Price
- USPH $84.61
- NAGE $9.77
- Analyst Decision
- USPH Strong Buy
- NAGE Strong Buy
- Analyst Count
- USPH 4
- NAGE 3
- Target Price
- USPH $110.25
- NAGE $17.00
- AVG Volume (30 Days)
- USPH 189.6K
- NAGE 1.1M
- Earning Date
- USPH 08-06-2025
- NAGE 08-06-2025
- Dividend Yield
- USPH 2.13%
- NAGE N/A
- EPS Growth
- USPH 116.39
- NAGE N/A
- EPS
- USPH 2.29
- NAGE 0.22
- Revenue
- USPH $722,201,000.00
- NAGE $116,303,000.00
- Revenue This Year
- USPH $18.74
- NAGE $28.46
- Revenue Next Year
- USPH $6.07
- NAGE $21.65
- P/E Ratio
- USPH $36.92
- NAGE $45.39
- Revenue Growth
- USPH 16.25
- NAGE 35.90
- 52 Week Low
- USPH $62.77
- NAGE $3.10
- 52 Week High
- USPH $101.20
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- USPH 57.16
- NAGE 45.41
- Support Level
- USPH $83.40
- NAGE $9.37
- Resistance Level
- USPH $88.39
- NAGE $10.31
- Average True Range (ATR)
- USPH 2.61
- NAGE 0.47
- MACD
- USPH -0.11
- NAGE 0.09
- Stochastic Oscillator
- USPH 44.51
- NAGE 32.92
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.